Covance Opens Fit-for-Purpose Dallas Clinical Research Unit Read more about Covance Opens Fit-for-Purpose Dallas Clinical Research Unit
LabCorp is Scheduled to Present at the Morgan Stanley Global Healthcare Conference Read more about LabCorp is Scheduled to Present at the Morgan Stanley Global Healthcare Conference
Laboratory Corporation of America® Holdings Announces 2015 Third Quarter Results Read more about Laboratory Corporation of America® Holdings Announces 2015 Third Quarter Results
LabCorp Acquires Safe Foods International Holdings Read more about LabCorp Acquires Safe Foods International Holdings
Covance Receives Frost & Sullivan Asia Pacific CRO Growth Excellence Leadership Award Two Years in a Row Read more about Covance Receives Frost & Sullivan Asia Pacific CRO Growth Excellence Leadership Award Two Years in a Row
LabCorp to Offer New PD-L1 Test for Bristol-Myers Squibb’s OPDIVO® Following Collaboration in Clinical Trial Read more about LabCorp to Offer New PD-L1 Test for Bristol-Myers Squibb’s OPDIVO® Following Collaboration in Clinical Trial
LabCorp to Follow Pivotal Role in Clinical Trial of Merck’s Keytruda® by Offering PD-L1 Companion Diagnostic Read more about LabCorp to Follow Pivotal Role in Clinical Trial of Merck’s Keytruda® by Offering PD-L1 Companion Diagnostic
Bode Cellmark Forensics Enters into Service Agreement in Support of Innovative Programs Dedicated to Processing Sexual Assault Kits Nationwide Read more about Bode Cellmark Forensics Enters into Service Agreement in Support of Innovative Programs Dedicated to Processing Sexual Assault Kits Nationwide
Conversion Right Triggered for LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021 Read more about Conversion Right Triggered for LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021
Covance to Open Second Current Good Manufacturing Practice (cGMP) Pharmacy in U.S. Read more about Covance to Open Second Current Good Manufacturing Practice (cGMP) Pharmacy in U.S.
